Dangerous Side Effects of Benicar

Posted on January 23, 2016

The U.S. Food and Drug Administration (FDA) has issued warnings about severe gastrointestinal side effects from using the blood pressure medication Benicar (olmesartan medoxomil). Japanese pharmaceutical giant Daiichi Sankyo spent approximately $1 billion to promote Benicar and Benicar HCT between 2002 and 2008, claiming it was superior to other angiotensin receptor blockers (ARBs). But, now the manufacturer is facing many lawsuits in relation to the drug which has been prescribed to over 11 million Americans.

After a Mayo Clinic study linked Benicar to gastrointestinal complications including severe chronic diarrhea and drastic weight loss, the FDA issued warnings about the drug. Some Benicar users have developed a serious condition known as villous atrophy. This is when the inside of the intestine loses its texture, making it difficult to absorb nutrients. This condition can lead to severe malnutrition and other health problems.

If you or a loved one has suffered an injury due to being prescribed Benicar, you could pursue compensation for the following damages:

  • Current medical bills
  • Future medical bills (for a chronic condition or future surgeries)
  • Pain and suffering
  • Lost wages from missed work
  • Loss of career or earning capacity
  • Hedonic damages (loss of enjoyment of life)

Pharmaceutical manufacturers have a duty of care to make sure their products are tested and safe before they are put on the market and prescribed to patients. When this duty of care isn’t observed, the patient has a right to take legal action. To get proper compensation for your losses, you need to contact a pharmaceutical litigation attorney.

Farah & Farah is investigating pharmaceutical litigation cases nationwide. We’;re ready to fight for you against the big drug companies. Call us today at (800) 533-3555.

  • This field is for validation purposes and should be left unchanged.